Medicare patients have low adherence to biologic drug therapy for psoriasis
About half of Medicare patients who start taking biologic therapies for moderate to severe plaque psoriasis stop within a year, according to a new study led by researchers from the Perelman School of Medicine at the University ...
Apr 25, 2016
0
3